ad image

Antibiotics

1 / 2
Kinvard Bio
Antibiotics

Kineticos Launches Kinvard Bio to Advance Next-Generation Antibiotics in the Fight Against Antimicrobial Resistance

Kinvard Bio

PR-02-25-NI-27Feb 24, 2025
The Potential of Molecular Machines: Enhanced Drug Delivery and Beyond
Molecular Machines

The Potential of Molecular Machines: Enhanced Drug Delivery and Beyond

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-01-24-NI-02Jan 22, 2024
Antibiotic Resistance: Advances in Understanding and Drug Development
Antibiotic Resistance

Antibiotic Resistance: Advances in Understanding and Drug Development

David Alvaro, Ph.D.

Pharma's Almanac

PAO-10-022-NI-07Oct 11, 2022
Preserving the Value of Critical Anti-Infectives
Antimicrobial

Preserving the Value of Critical Anti-Infectives

Centrient Pharmaceuticals

PAO-04-22-R221-20Apr 14, 2021
Sandoz
Antibiotics

Sandoz Announces Plans for Joint Investment to Help Strengthen Future of Antibiotics Manufacturing in Europe

Sandoz

PR-M07-20-NI-38Jul 27, 2020
Drug Approval Trends: Significant Acceleration in Recent Years
Nice Insight Overview

Drug Approval Trends: Significant Acceleration in Recent Years

Nigel Walker

Nice Insight

PAP-Q2-20-NI-001Jul 01, 2020
Molecules that Changed Medicine
Molecules

Molecules that Changed Medicine

Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.

Pharma's Almanac

PAP-Q2-20-NI-002Jul 01, 2020
Applying a Synthetic Approach to the Development of a New Generation of Antibiotics
Novel Antibiotics

Applying a Synthetic Approach to the Development of a New Generation of Antibiotics

James Graham

Recce Pharmaceuticals Ltd.

PAP-Q2-20-CL-019Jul 01, 2020
U.S. Food & Drug Administration
FDA Approval

FDA Approves New Antibiotic to Treat Community-Acquired Bacterial Pneumonia

U.S. Food & Drug Administration

PR-M08-19-NI-061Aug 21, 2019
UK Hopes Subscription Payment Model Will Drive Innovation in Antibiotics
Antibiotics

UK Hopes Subscription Payment Model Will Drive Innovation in Antibiotics

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-M08-19-NI-006Aug 01, 2019
Melinta’s Antibiotic Baxdela Gets Priority Review from FDA for CAPB
Priority Review

Melinta’s Antibiotic Baxdela Gets Priority Review from FDA for CAPB

Pharma's Almanac

PAO-M07-19-NI-005Jul 01, 2019
Florida International University
Antibiotic Resistant

FIU Scientists Discover New Arsenic-Based Broad-Spectrum Antibiotic

Florida International University

PR-M04-19-NI-058Apr 18, 2019
Infectious Diseases Experts Convene to Explore Lifesaving Antibiotic Research Methods
Antibiotics

Infectious Diseases Experts Convene to Explore Lifesaving Antibiotic Research Methods

Nice Insight

PR-M11-18-NI-052Nov 15, 2018
Qpex Biopharma
Investment

Qpex Biopharma Announces Closing of $33 Million Series A Financing and Launch of Company to Address Worldwide Problem of Drug-Resistant Infections

Qpex Biopharma

PR-M10-18-NI-087Oct 25, 2018
PolyPid
Antibiotics

PolyPid Begins Phase 2 Study to Assess Safety and Efficacy of D-PLEX100 in Prevention of Abdominal Surgical Site Infections

PolyPid

PR-M10-18-NI-070Oct 19, 2018
Menarini Group
Antibiotics

The Menarini Group Announces Commercial Agreement for Vabomere, Orbactiv and Minocin in 68 Countries

Menarini Group

PR-M10-18-NI-048Oct 15, 2018
New Antibiotic to be Tested against Potential Bioweapons
Drug Development

New Antibiotic to be Tested against Potential Bioweapons

Emilie Branch

Pharma's Almanac

PAO-M07-18-NI-009Jul 17, 2018
Roche
Antibiotic Resistance

Roche PCT assay cleared for expanded use - Important tool in antibiotic resistance crisis

Roche

PR-M07-18-NI-049Jul 16, 2018
Funding Round Will Boost Efforts to Develop Antibiotic for Alzheimer’s Disease
Innovation

Funding Round Will Boost Efforts to Develop Antibiotic for Alzheimer’s Disease

Nigel Walker

Nice Insight

PAO-M06-18-NI-005Jun 05, 2018
Macrolide Attracts Funding and Executive Talent
Antibiotics

Macrolide Attracts Funding and Executive Talent

Nigel Walker

Nice Insight

PAO-M04-18-NI-004Apr 04, 2018
1 / 2